Welcome to Fuglsang Pharma
Fuglsang Pharma provides consultancy and audit services for companies involved in the development, testing or production of medicines and medical devices.
The primary activities are:
- Development of clinical and regulatory strategies for innovator drugs.
- Development of clinical and regulatory strategies for generic drugs.
- Auditing according to the GLP, GCP and ISO standards.
This site is owned by Anders Fuglsang, who is a former EU regulator (clinical assessor) and who managed the international group of assessors that established the EU guidelines for proof of therapeutic equivalence that came into force in 2009.
A.F. was an expert advisor to the WHO, member of the Efficacy Working Party at EMEA (EMA), member of the PK subgroup, and has worked with both generic and innovator companies. A.F. is Danish by nationality.